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ABSTRACT
DYNAMICS OF MICROTUBULE NETWORKS WITH ANTIPARALLEL CROSSLINKERS

MAY 2016
KASIMIRA T. STANHOPE, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Jennifer Ross

Microtubules are the most rigid element of the cytoskeleton. They are responsible for the
structure of cells and make up the tracks for intracellular cargo transport. Interactions
between microtubules, motor proteins, and microtubule-associated proteins drive
important mechanisms in the cell, such as cell division, cell motility, cell homeostasis, and
cell signaling. I seek to understand how such complex, energy-consuming non-equilibrium
biological networks self-organize by studying in vitro microtubules bundled by
microtubule-associated protein 65 (MAP65), in kinesin-1 gliding assays. I found that large
networks can break into smaller, cell-like networks that can mimic types of cell
motility. Dynamics of these networks change with varying concentrations of MAP65 and
microtubules
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CHAPTER 1
DYNAMICS OF MICROTUBULE NETWORKS WITH ANTIPARALLEL CROSSLINKERS

1.1 Introduction
Microtubules (MTs) are made up of alpha and beta tubulin dimers that form a tube

of protofilaments with a cross-sectional diameter of 25 nm and can be 1-100 μm in length.

They functionally have to be very ridged filaments and are known to have a persistence

length of about 1mm (Hawkins et al 2010). The alpha and beta tubulin dimers are GTPases
that always polymerize in the same direction, with one end exposing the alpha tubulin and

one end exposing the beta tubulin. The end with the beta-tubulin exposed in the “plus end”
that grows and shrinks faster than the alpha-exposed “minus end.” (Fig. 1)
Figure 1: Microtubules, Kinesin-1, and MAP65
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Microtubules have many interactions with motor proteins. These interactions drive

mitosis, cell signaling, and cell transport. Kinesin-1 is very important in active transport of
signals in neurons (Goldstein and Yang 2000). This motor protein binds and walks along a
single protofilament of microtubules toward the plus-end (Fig. 1) with a step-size of about
8nm (Yildiz et al 2004). Kinesin-1’s motility is fueled by ATP hydrolysis using 1 ATP

molecule per step.

Cytoskeletal crosslinkers are important for microtubule organization in the cell. For

example, for mitosis to occur, microtubules in the kinetochore must be aligned parallel

while antiparallel microtubules are needed towards the outside of the spindle to drive the
forces for mitosis. MAP65 is part of a family of crosslinkers, including PCR1/Ase1, which

form antiparallel microtubule bundles (Fig. 1) that are needed for spindle formation during
metaphase, telophase, and cytokinesis (Jian et al 1998). MAP65 binds to microtubules and

dimerizes with other MAP65s bound to other microtubules to create a space of about 25-35
nm between antiparallel bundled microtubules (Chan et al 1999). At saturated

concentrations MAP65 will regularly space itself on microtubules to dimerize about every

35 nm (Gaillard et al 2008). MAP65 is a very strong crosslinker despite having such a short

residence time on a microtubule in both cells (Loïodice et al 2005) and in vitro

(Subramanian et al 2010, Pringle 2013). The residence time is also shown to increase due
to bundling (Bieling et al 2010).

Previous binding kinetics studies show that MAP65 has a KD value of ~1.2 μM when

binding with microtubules (Tulin et al 2012). Bundling microtubules with MAP65 yields

different phases of bundling resembling gas, liquid, and solid-like states as a stationary

bundle (Pringle et al 2013). A previous member of my lab added microtubules pre-bundled

by MAP65 to a motile flow chamber covered in kinesin-1 and observed an active state that
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resembled “cell-like” microtubule organizations (Pringle et al 2013). In my thesis, I sought

to expand on his observations of these “cell-like” organizations. This system is an example

of an active material displaying non-equilibrium physics, which is very interesting and not
sufficiently explored.

For my Master’s work, I have uncovered the state diagram of motile microtubule

organization in the presence of various concentrations of MAP65 and microtubules. I

performed experiments and analysis to categorize and identify dynamics of movement
observed at each concentration of microtubules and MAP65. There are three phases

observed by these experiments. Some bundles are extensile and are pulled completely
apart by kinesin-1 motility and reach a homogeneous organization. Some bundles are

contractile and create “cell-like” organization, sometimes resembling cytokinesis or a
crawling amoeba. These organizations are ultimately either pulled apart, or they are

released into the chamber remaining as crosslinked networks no longer in contact with the
kinesin-coated surface. Other bundles contract while microtubules are pulled away from

the bundle, then stop moving. My work supports previous observations that microtubules
are slowed down by MAP65/PRC1 (Janson et al 2007, Subramanian et al 2010, Pringle

2013). I believe the halting of movement is due to the antiparallel bundles becoming a

“knot” because it no longer has any microtubules that can be pulled free due to the bundling
by MAP65. There are also bundles that do not move at all when activated. I have also
explored the dynamics of bundling free microtubules while flowing MAP65 into the
chamber. These experiments measure the dynamics of bundling as a function of
microtubule and MAP65 concentrations.
1.2 Results and Discussion
1.2.1 Pre-Bundled Network Organization with MAP65 and Kinesin-1 Gliding
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In this section of this chapter I focus on Huxley's contribution to the evidence

favoring the application of the theory of evolution to human beings. I performed in vitro

reconstitution experiments combining microtubules and MAP65 at specific concentrations.
In order to determine the percentage of tubulin in the microtubule with MAP65 bound, I
used the hyperbolic function:

𝐾𝐷 =

[𝑇𝑇𝑇]𝑓𝑓𝑓𝑓 [𝑀𝑀𝑃65]𝑓𝑓𝑓𝑓
[𝑀𝑀𝑀65−𝑇𝑇𝑇]𝑏𝑏𝑏𝑏𝑏

Eq 1.

[MT] added

[MAP65] added

% MT bound

1

0.3

12.87

(μM)

(μM)

1

0.98

2.5

0.5

1

2.5

1.74
1

by MAP65
34.56
50.68
12.89
24.46

2.5

1.5

2.5

2.5

5

0.82

5

2.3

33.77

1.2

12.8

2.5
2.5
5
5
8

10

Table 1: % Microtubule Bound

34.6

2

43.32

3

56.82

1.6
3.1

1.48

4

50.68
12.86
24.3
43.5

12.83

Where KD is the equilibrium dissociation constant, [MAP65] is the concentration of free

MAP65 in the solution, [Tub] is the concentration of tubulin without a MAP65 bound, and
[MAP65-Tub] is the concentration of tubulin and MAP65 bound. From prior work, we

assume KD ~1.2 μM (Tulin 2011). Table 1 shows the concentrations of MAP65 we added,

and the calculated percentage of MAP65 bound for each, calculated using equation 1.

Using the known percentages of MAP65 bound and how that corresponds to the

phase of network formation, previously determined by the Ross Lab (Pringle 2013), I added
the bundled networks of filaments to a microtubule gliding assay powered by kinesin-1

motor proteins and imaged the results using epi-fluorescence. A motility mix including ATP

and an ATP regenerating system is used because it can take hours to observe a bundle come
to some sort of equilibrium. First, I systematically varied the crosslinker concentration

while keeping the amount of microtubules constant. Next, I held the percentage of MAP65
bound constant, while altering the microtubule density (Table 1).
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1.2.1.1 Types of Activity Observed
Figure 2: Raw Data
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Figure 2 shows example activities/patterns that I observed in mixtures of

microtubules and MAP65. One common result was “extensile” activity, where bundles are
being completely pulled apart by the kinesin-1 on the cover slip surface (Fig. 2A). This

activity was particularly prominent at low MAP65 density. Networks of microtubules are

bundled in the test tube but are pulled apart readily by the kinesin-1. There is not enough
MAP65 to hold the bundles together.

At relatively high densities of MAP65 crosslinker, the networks display a frozen

phase where there is no motion (Fig. 2B). In this case, I speculate that the crosslinkers are
holding the bundle tightly and withstanding the kinesin-1 motility, effectively stalling the
motors. We see such frozen states at the highest densities of crosslinkers.

At an intermediate regime, bundled networks contract (overall become smaller)

after being added to the chamber with kinesin-1 (Fig. 2C). This is particularly interesting, as
all prior work with kinesin-1 motors have shown extension. At long times (>15 minutes)

these networks become pulled apart or they will either stop. Sometimes, the organizations
will yield the “cell-like” organizations we saw previously (Pringle 2013).

This intermediate regime is surprising for the displayed short-term contraction and the

long-term cell-like organizations. At a certain ratio of microtubules to MAP65, networks of

antiparallel bundles will show a lot of pulling, knotting, and kinking in these contractile and

“cell-like” phases (Fig. 2C). The networks that stop must have enough MAP65 concentrated
in the center from the contraction to stall the kinesin while free MTs are still motile.
1.2.1.2 Quantitative Analysis

7

Figure 3: Data Analysis

Although the differences described above could be detected by eye, we sought to

have an automated method to identify different activities. Working with a postdoc in the

lab, Dr. Vikrant Yadav, we developed a MatLab code to identify the boundary of the network

for each frame and then compute statistics about the network outline (Fig. 3). For each
frame, the network was outlined and the center of mass was computed. The standard

deviation (σ) from the each edge point to the average center of mass was also computed.

The standard deviation is a measure of the size of the network. The standard deviation was
normalized compared to the initial size (standard deviation) by dividing each time frame’s
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standard deviation by the initial frame’s standard deviation you get the relative standard
deviation. That relative standard deviation was averaged for many networks at the same

conditions (microtubule and MAP65 concentrations) and plotted versus time (Fig. 4). Error
bars represent the standard error of the mean of the averages. When you plot the relative

standard deviation vs. time, the trend is linear for the first 15 minutes of data. We fit a line
of the form:

𝑦 = 𝑚𝑚 + 𝑏

Eq 2.

using a least squares fitting algorithm to find the best fit the slope. This slope represents

spreading speed of the network relative to the center of mass and edge of the original frame
(Fig. 4,6).

Figure 4: Relative Standard Dev. vs. Time
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Figure 5: Spreading Speed vs. Crosslinker Density

For networks that are extensile and pulled apart, the spreading speed (slope) is

positive because the edge of the network is detected going further away form the average

center of mass. Networks that contract display negative spreading velocities as the bundles
are concentrated into the center of the network and the edge is detected getting closer to

the center of mass. Frozen networks have a zero slope indicating no change in the standard
deviation over time (Fig. 5,7).
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Figure 6: Relative Standard Dev. vs. Time
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Figure 7: Spreading Speed vs. [MT]

1.2.1.3 Activity as a Function of Crosslinker Density
We performed these experiments and analysis for a fixed concentration of

microtubules (1 μM, 2.5 μm, 5 μM, 8 μM, and 10 μM) and systematically altered the MAP65
concentration. Figure 4 shows a data scan with 2.5 μM microtubules added and 12.89% to

56.82% MAP65 binding to microtubules. At the lowest MAP65 concentration, the spreading
speed is highest (~8.5x10-4 nm/s). As the concentration of MAP65 increases, the spreading

speed decreases. Eventually, at around 34%, the spreading speed becomes negative

indicating contraction of the network. At high concentrations of MAP65, the network
becomes frozen with a zero slope spreading speed. (Fig. 5)
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1.2.1.4 Activity as a Function of Microtubule Density
As described above, we wanted to systematically alter the microtubule density,

while holding the percentage of MAP65 crosslinkers constant. In order to do that, the
crosslinker concentration was also varied according to equation 1. One particular

crosslinker density I studiesd was 12% MAP65 binding with microtubules at various

concentrations. The same analysis was performed for this data and the spreading speed was
determined by linear fits (Fig. 6). The determined spreading speed was plotted as a

function of microtubule concentration and a similar dependence is observed with an initial
extensile activity (positive spreading speed) that becomes contractile (negative spreading

speed) and then frozen (Fig. 7). Interestingly, at 12% MAP65 binding, we still observed
contraction when the amount of microtubules is 8 μM.

Figure 8: State Diagram

Fig.8: By changing the concentrations of the components we can see that
there is a small regime where bundles will contract as you increase
protein density before becoming frozen
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Using all our data collected for a variety of concentration, we can create a state

diagram of activity plotted against the microtubule concentration and MAP65 percentage of
binding (Fig. 8). Interestingly, we see the low MAP65 and low microtubule concentrations

are extensile and the highest concentrations of both are frozen. In the intermediate regime,
we see contractile networks.

1.2.1.5 Tracer Experiments
Figure 9: Low Density Tracer Experiments

A) 99% Rhodamine Labeled

B) 1% HiLyte 647 Labeled (Tracer)

C) 1% HiLyte 647 Labeled (Tracer zoomed in)
Tracer microtubules in a different fluorescence show knotting of individual
microtubules/bundles in a contractile system that later becomes frozen.
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Each frame after the first has a Δt of 500s. This is a sample of 5μM MTs and
3.1μM MAP65 (43.5% bound)

In the data above, the networks had all the microtubules labeled to show the overall

network organization. I was also interested in how individual microtubules acted within
the networks during these activities. In order to examine this, I performed experiments

with differentially labeled microtubules (red or dark red) mixed in at a low density (1:100)
with labeled microtubules of the other color (dark red or red) that made up the bulk of the
network. I could track the low density microtubules as individuals while simultaneously
tracking the network architecture. (Fig. 9) I observed that individual bundles and

microtubules in the network appear to bend in these contractile and even extensile
networks.

1.2.1.6 Control Experiments
Figure 10: PEG Controls

Show that PEG creates bundles that are weak enough to be readily pulled apart

even at high concentrations. This is a sample of 2.5μM MTs and 5% 40 kD PEG.

I performed a control experiment bundling microtubules with poly-ethylene glycol (PEG).
PEG is an inert polymer that bundles microtubules non-specifically through the depletion

force (osmotic pressure). We added 5% 40 kD PEG bundles to kinesin-1 gliding assays, as
above. PEG bundles are not ever as intense as the MAP65 bundles because PEG can only

bundle microtubules so much until the osmotic pressure pushes PEG inside the bundles and
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microtubules making them less bundled. We observed bundles that would be pulled apart
readily as expected even at high concentrations. (Fig. 10)
1.2.2 Flow-In Experiments with MAP65 Bundling

Figure 11: Flow-In Bundling
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In order to examine the dynamics of MAP65 bundling, I performed a series of

experiments bundling microtubules with MAP65 while observing in a flow chamber. These
experiments are done by first imaging microtubules in a chamber with no delay, then

adding a mixture of MAP65 to capture how the microtubules bundle over time. The control
shows the microtubules aligning due to flow then becoming freely diffusing again over
time. At low MAP65 concentrations, the same behavior is also observed. This is likely

because there was not enough MAP65 to crosslink microtubules. As the concentration of

MAP65 increases, the intensity of the bundles also increase (Fig. 11). This data has not yet

been analyzed quantitatively, but will be done using ImageJ to compare relative intensities
of bundles forming after the flow through.

1.2.3 Conclusions/Future Work
From these experiments I conclude that low crosslinker density leads to extensile

activity, medium crosslinker density causes contractile activity, and high crosslinker density
cause frozen, non-motile systems. The evidence of a contractile system involving kinesin-1

and MTs is rare relative to actin-myosin systems (citations here for actin-myosin), so these

findings are very interesting. I am working to complete the state diagram by performing
more experiments at 8 μM and 10 μM microtubules.

We are working with a theorist, Dr. Art Evans, currently a postdoc at the University

of Wisconsin, to model our system. He has created simulations where he can alter the

interaction strength between microtubules and the gliding speeds and friction. He is still

running the simulation, but he sees similar phenomena in his simulations as we observe in
experiments.
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1.3 Methods
1.3.1 Making Labeled Cytoskeleton Taxol Stabilized Microtubules
Tubulin dimers are bought from the company Cytoskeleton. The lyophilized pellets

are dissolved in our working buffer PEM-100 to make a concentration of 5 mg/mL. To

make microtubules visible with epi-fluorescence, we combine the labeled and unlabeled
tubulin to make a mixture of about 10% labeled. We centrifuge the tubulin mixture at
366,000 xg for 10 min at 4°C to pellet aggregated and misfolded tubulin from the

supernatant of properly folded tubulin. Next, 1 mM GTP is added to the supernatant and
incubated at 37°C for at least 20 minutes to allow for dynamic polymerizing and

depolymerizing of microtubules. Next, 50 μM of Taxol is then added to the mix and

incubated at 37°C for at least 20 minutes to allow for static polymerization creating long
stable microtubules. We centrifuge the mixture at 16,200 xg for 10 min at room

temperature to pellet the microtubules from the supernatant of inactive tubulin dimers.
Finally, we resuspend the pellet of microtubules in 50 μM taxol and add PEM-100 to the
original volume.

1.3.2 Kinesin-1 Purification
Transform competent BL21 E. coli cells with the pet21-GFP-Kin560-6xHis plasmid

containing ampicillin resistance using LB, then plate. Create starter cultures using about 15
colonies and 5mL of terrific broth media and allow to shake at 37°C until cloudy. Cells are
added to a larger culture and grown at 37°C to an O.D. at A600 of 1-2 then induced with

0.2mM IPTG. Induced cells are shaken overnight at room temperature for 16 hours.
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Centrifuge induced cells to pellet the cells away from the media then allow the pellet to

freeze for at least an hour. Resuspend and lyse the cell pellet in a lysis buffer (50mM pH8

sodium phosphate buffer, 250mM NaCl, 2μm/mL aprotonin, 2μm/mL leupeptin, 2μm/mL
pepstatin, 0.5mM ATP, 1% Tween-20, 2mg/mL lysozyme and DnaseI) using sonication.

Allow the cell lysate to incubate with silicon-nickel beads and 20.67mM imidazole at 4°C for

1.5 hours. The lysate/bead mixture was added to the column and allowed to enter

completely. The column is then washed with 25mL of wash buffer (50mM pH6 sodium

phosphate buffer, 250mM NaCl, 1mM MgCl2, and 100μM ATP). Then the protein is eluted in
elution buffer (50mM pH7.2 sodium phosphate buffer, 500mM imidazole, 250mM NaCl,

1mM MgCl2, and 100μM ATP). The protein is then buffer exchanged using a NAP-5 column

into our working buffer PEM-100 with 100μM ATP. Add 10% sucrose, drop freeze in liquid
nitrogen and store at -80°C. The approximate concentration of the full kinesin construct is
measured using BSA standards and SDS-page due to truncation.

1.3.3 MAP65 Purification
Transform competent BL21 E. coli cells with the pet28a-MAP65-6xHis plasmid

containing kanamycin resistance using LB, then plate. Create starter cultures using about
15 colonies and 5mL of terrific broth media and allow to shake at 37°C until cloudy. Cells

are added to a larger culture and grown at 37°C to an O.D. at A600 of 0.6-1 then induced with

1mM IPTG. Induced cells are shaken overnight at 20°C for 16 hours. Centrifuge induced

cells to pellet the cells away from the media then allow the pellet to freeze for at least an
hour. Resuspend and lyse the cell pellet in 5mL lysis buffer (50mM Tris pH8, 20mM

imidazole pH8, 500mM NaCl, 10% glycerol, and 1% Tween-20) per gram cell pellet using

sonication five times for 30 seconds recovering on ice 5 minutes in between. Allow the cell
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lysate to incubate with silicon-nickel beads and 20.67mM imidazole at 4°C for 1.5 hours.

The lysate/bead mixture was added to the column and allowed to enter completely. The

column is then washed with 25mL of wash buffer (50mM Tris pH8, 20mM imidazolepH8,
500mM NaCl, and 10% glycerol). Then the protein is eluted in elution buffer (50mM Tris
pH8, 250mM imidazole pH8, 500mM NaCl, and 10% glycerol). The protein is then buffer

exchanged using a NAP-5 column into our working buffer PEM-100 with 100μM ATP. Drop

freeze in liquid nitrogen and store at -80°C. The approximate concentration of the protein is

measured using a Bradford assay.

1.3.4 Pre-Bundled Gliding Assay with MAP65
I make a 10μL flow chamber using a coverglass, double-stick tape and a coverslip. I

prebundle my microtubules in what will become the ATP regenerating motility mix by

adding the microtubules and MAP65 to 35μM taxol, 35μM DTT and PEM-100. I allow the

microtubules to incubate with the crosslinkers for 30 minutes. I flow through and fill the
chamber with kinesin and incubate at room temperature for 5 minutes. During the

incubation I add the remaining components to the bundled microtubules to complete the
motility mix (1 mM ATP, 1.9 μM phosphocreatine, 68 μg/ml creatine phosphokinase, 4.3
mg/mL glucose, and 0.4 μl deoxy for every 10 μl, volume with PEM-100). I then flow

through a BSA chamber wash (5mg/mL BSA, 60 μM taxol, 20 mM DTT, volume with PEM100). I immediately flow through the motility mix then image using epi-fluorescence.
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1.3.5 Flow in Bundling Experiments
A cross-flow chamber is made then filled with a dilution of microtubules into PEM-

100 and taxol. The slide is then brought to image along with a prepared MAP65 and taxol

mix. The chamber is imaged using epi-fluorescence to capture a movie of the flow-in of the
MAP65 mix bundling (or not bundling) the microtubules. No incubation times are needed.
Movies should be taken without delay because bundling happens quickly.
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APPENDIX
PROTOCOLS

% MT bound by MAP65 Calculation:
We know that KD is ~1.2μM

KD in this case is {([MTadded]-[MT-MAPbound])([MAPadded]-[MT-MAPbound])} / [MT-MAPbound]

We want to find [MT-MAPbound] from KD to calculate % MT bound by MAP65 ([MTMAPbound]/ [MTadded])

So we use the quadratic equation to find [MT-MAPbound] because:

0 = ([MT-MAPbound])2 – (KD+[MTadded]+[MAPadded])([MT-MAPbound])+([MTadded][MAPadded])
General Buffer:
PEM-100 Buffer: 100mM Na-PIPES, 1mM MgSO4, 1mM EGTA, pH 6.8, store in 4°C.
Making Cytoskeleton Taxol Stabilized Microtubules: _____% labeled

Unlabeled Cytoskeleton Tubulin: The stock comes in a pellet that needs 200μL of PEM-100
added to it to be at 5mg/mL (on ice). Aliquot and drop freeze from stock. Keep sticker on
tube in notebook.
Labeled Cytoskeleton Tubulin: Add 4μL PEM-100 to resuspend pellet to 5mg/mL before
use. Keep sticker on tube in notebook.
Turn on large Sorvall Discovery M120 centrifuge, set to 4°C. Make sure vacuum is on.
Thaw/resuspend tubulin on ice. Transfer:

_____μL labeled + _____μL unlabeled = _____μL Total

into open round-bottom centrifuge tubes. (Make balance of same volume!)
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Using the small S120AT2-0449 rotor in deli fridge, centrifuge @ 90,000rpm for 10 min.
Thaw aliquot of 100mM GTP for next step.
Discard pellet & transfer sup to a 1.5mL epp. tube. Add _____μL 100mM GTP (1mM GTP
Final).
Incubate for 20 min @ 37°C.

Add _____μL 2mM Taxol (50μM Taxol Final).
Incubate for 20 min @ 37°C.

Using table-top centrifuge 5415 R, centrifuge at 13,200rpm (top speed) @ 25°C for 10
minutes. (Make a balance of same vol.!)
Discard sup & resuspend pellet in:

_____μL 2mM Taxol + _____μL PEM-100 = _____μL Total

*Use same vol. of Taxol as in step 6 and add PEM-100 to the same total vol. in step 2.

**Clean 25μL Hamilton syringe with ddH2O (fill and expel at least 3x). Use syringe to
resuspend pellet (fill and expel at least 3x - try not to introduce bubbles).**
Incubate overnight @37°C (~3 nights max).

**Use syringe to declump again before use.**
Kinesin-1 Purification

Day One, Transformation:
Thaw BL21 cells on ice (if you’re also doing a miniprep thaw DH5-alpha cells too)
While cells are thawing, put agar plates in 37°C incubator
Add 5μL of plasmid to cells

Incubate on ice for 30 minutes

Heat shock @ 47°C for EXACTLY 45 seconds

IMMEDIATELY incubate on ice for 2 minutes
Add 400μL of LB

Incubate @ 37°C for 1 hour

During incubation plate 50μL of 100 mg/mL ampicillin
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Once incubation is done plate 100μL of transformed cells
Incubate overnight @ 37°C

Make 500 mL Terrific Broth media in 1L flask:
8g Tryptone

6g Yeast Extract
1.6g NaCl

0.8g Na2HPO4

0.4g KH2PO4

Add dH2O to bring final volume to 395.6 mL and autoclave
*4 mL 20% Glucose

*400 μL 100 mg/ml Ampicillin

growing cells)

*add to media after autoclaved (same day

Make buffers if needed (sterile filter and store in 4oC):
Lysis Buffer:

Wash Buffer:

250 mM NaCl

250 mM NaCl

50 mM NaPO4, pH 8.0 50 mM NaPO4, pH 6.0

Elution Buffer:

50 mM NaPO4, pH 7.2

500 mM Imidazole

1 mM MgCl2

250 mM NaCl

1 mM MgCl2

Day Two, Induction:
1. First thing in the morning, make 5 mL starter culture:
5 mL TPM media

50 μL 20% Glucose

5 μL 100mg/ml Ampicillin

15 colonies from transformation plate
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2. Incubate starter culture on 37oC shaker until culture is cloudy (approximately 2 hours)

3. Once starter culture is cloudy, add to 400 mL TPM media (*add glucose and ampicillin to
TPM media). Set aside 2 ml of media without bacteria for control on the OD600.

4. Grow cells to OD 1-2 (ideal 1.7) in TPM media. Monitor the growth using OD600.
5. Let culture cool to room temperature (save 20uL for pre-induced sample)

6. Induce with IPTG (final concentration of 0.2 mM)

7. Shake at room temp overnight.

Day Three, Protein Purification:
1. Save 20 μl induced cells for gel sample (Induced Cells).

Spin down cells for 10 minutes at 4oC, 5,000 rpm

2. Pour off supernatant, freeze pellet in -80oC for 1 hour

**pellet can also be left at -80oC for purification on a different day**

3. Put pellet on ice and resuspend in 30mL cold Lysis Buffer (keep on ice during
resuspension)
To Lysis buffer, add: 30 μl 2mg/mL Aprotonin
30 μl 2mg/mL Leupeptin

30 μl 2mg/mL Pepstatin

30 μl Tween-20

150 μl 100mM ATP

4. Add 62mg Lysozyme

5. Rock at 4oC for 20 minutes
6. Add 15ul DnaseI (Sigma)

7. Sonicate 1 minute on ice (setting 3)

8. Centrifuge 30 minutes, 4oC, 40,000xg (T865 rotor)

9. Save a small sample of the pellet (dark brown) as gel sample. Save 20 µl of the
supernatant as gel sample.
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Bead Equilibration: (if you have a Ni column, this is not needed)

*put beads on rocker for ~30 minutes to get beads fully into solution before using
1. Add 500ul Ni beads to 2mL tube, add 1.5mL Lysis Buffer, invert tube 10 times, spin 2 min
at 500xg, remove sup without disturbing bead bed
2. Repeat for a total of 4 times

3. Pour supernatant into 50mL conical tube Take a 20 μL gel sample.
4. Add 620 μl 1M Imidazole to supernatant

5. Add some supernatant to beads, and bring back and forth to get beads into supernatant
conical
6. Incubate at 4oC on rocker for 1.5 hours
Buffers with ATP:
Wash Buffer:

Elution Buffer:

PEM-100:

25 mL Wash Buffer

2.5 mL Elution Buffer

12 mL PEM-100

25 μL 100mM ATP

2.5 μL 100mM ATP

12 μL 100 mM ATP

1. Flow Lysate sup+beads through column (*gel sample of FT*)

*Lysate FT may be put in -80oC freezer and used for another purification

2. Flow 25mL Wash Buffer (with ATP added) over column (*gel sample of FT*)

3. Flow 150 μL Elution Buffer+ATP over column and collect first fraction (*gel sample*)
4. Flow 500 μL Elution Buffer+ATP over column for fractions 2-5 (*gel samples*)

*kinesin will usually be in fraction 2 (sometimes I make all fractions 150uL to make it more
concentrated)
5. dot blot to verify fraction containing kinesin:

-with pencil, draw 5 circles on a piece of fliter paper, label circles Elutions 1-5
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-add 0.5 μL of each fraction to respective circles
-stain with coomassie for 30 seconds
-destain, observe the glory

Buffer Exchange:

1. Remove top and bottom cap of NAP-5 column

2. Allow buffer to completely drain by gravity flow

3. Add 10 mL PEM-100+ATP and allow to completely enter gel bed
4. Add 500 μL of elution with protein (determined by dot blot)
5. Put new 1.5 mL tube under column

6. Add 1 mL PEM-100+ATP and collect eluate (you may want to break this up into multiple
small volumes and do another dot blot to determine which fractions to use to make more
concentrated) (*20 μL gel sample*)
7. Add 200 μL 60% sucrose (10% final concentration) to buffer exchanged kinesin
8. Aliquot

9. Drop freeze in liquid nitrogen and store in -80oC
MAP65 Purification
Buffers:

Terrific Broth Media: 6g tryptone, 12g yeast, 2mL 100% glycerol, and volume to 450mL w/
ddH2O
Potassium Phosphate Buffer: 1.16g KH2PO4, 6.25g K2HPO4, volume with ddH2O to 50mL,
pH~7

Lysis Buffer: 50mM Tris pH8, 20mM imidazole pH8, 500mM NaCl, 10% glycerol, and 1%
Tween-20
Wash Buffer: 50mM Tris pH8, 20mM imidazolepH8, 500mM NaCl, and 10% glycerol

Elution Buffer: 50mM Tris pH8, 250mM imidazole pH8, 500mM NaCl, and 10% glycerol
Day 1, Transformation
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Transform E. coli BL21(DE3) or Rosetta(DE3) cells with pET28a-based expression vector
with your favorite gene. We typically use pET28a-TEV (pTEV), which has the TEV cleavage
site.
Plate cells on LB-Kanamycin (50 mg/l) and grow overnight at 37 °C.
Day 2, Inoculation/Induction

First thing in the morning, inoculate 5 ml LB-Kan culture with 15 colonies.

Grow at 37°C, 250 rpm until cloudy (approx. 2 hours).

Once starter culture is cloudy, inoculate 500ml Terrific Broth + Kanamycin (50 mg/l) with
the 5 ml culture and grow to a cell density of A600 of ~ 0.6-1.0. Set aside 2 ml of media
without bacteria for control on the OD600.
Monitor cell culture OD every 30-60 min.

Save 10 μl pre-induced cells for gel sample.

Induce protein expression by adding 1 M sterile IPTG to a final concentration of 1 mM IPTG.
Shake overnight hours at 20°C, 250 rpm. Low temperature induction is essential to prevent
protein aggregation and exclusion into inclusion bodies.
Save 10 μl induced cells for gel sample (Induced Cells).
Day 3, Purification

Save 10 μl induced cells for gel sample (Induced Cells). Harvest cells by centrifugation at
5000 xg, 10 min, RT in GSA bottles. Weigh the cell pellet (typically 3-4 grams per 500 ml).
Freeze the pellet at -20°C until ready to do protein purification, if needed.
Thaw the cell pellet at 37°C for 1-2 min and then keep on ice for 5 min.
From this point on, keep cells/lysate on ice at all times.

Resuspend cells in 5 ml ice-cold lysis buffer per gram cell pellet. Stir the pellet to resuspend
slowly at 4°C. Avoid frothing!!

Transfer cell suspension to a glass beaker and sonicate on ice for a total of 5 times, 60%
duty, power setting 6, for 30 s each time. Let the cells recover on ice for 5 min between each
cycle. Be careful to place the sonicator probe so that the tip is immersed in the center of the
resuspended pellet and NOT touching the side of the beaker.
At the end of sonication the lysate looks translucent.
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Centrifuge cell debris at 10,000 xg for 30 min 4 °C in SS34 rotor.

Do this while the centrifugation is occurring: Add 500 μl Ni beads to 2 ml tube, add 1.5 ml
Lysis Buffer, invert tube 10 times, spin 2 minutes at 500 xg, remove supernatent without
disturbing bead bed.
Repeat for a total of 4 times.

Transfer supernatant into fresh cold 50 ml tube immediately. Avoid getting any pellet in the
supernatant as this will clog the Ni column. Better to collect only 90-95% of the supernatant
to avoid getting any pellet contamination.
Save a small sample of the pellet (dark brown) as gel sample. Save 50 µl of the supernatant
as gel sample.
Use supernatant for Ni-bead purification.

Pour the entire supernatant fraction into a 50 ml conical tube. Take a 20 μl gel sample.
Add 620 μl 1M Imidazole to supernatant.

Add some supernatant to beads, and bring back and forth to get beads into supernatant
conical
Incubate at 4oC on rocker for 1.5 hours at 4°C.

Flow the supernatant with beads into the column. Catch the flow through in a 50 ml conical
tube labeled “Flow Through” and save a 20 μl gel sample. Save the Lysate Flow Through in
the -80°C for future purification.

Wash column once with 25 ml ice-cold Wash Buffer to remove unbound proteins. Save
sample for gel and stopper the column before the bed resin gets dry.

To elute protein, prepare 6 eppendorf tubes labeled with fraction numbers (1-6).

While the column is still stoppered, add 3 bed volumes of Elution Buffer and immediately
unstopper the column and collect fractions.
Fraction 1: 0.5 ml (mostly junk)

Fraction 2: ~ 1 ml (peak protein fraction)
Fractions 3-6: ~ 1 ml each.

Check for protein elution by performing a dot blot:

With pencil, draw 5 circles on a piece of fliter paper, label circles Elutions 1-5

Add 1 μl of each fraction to respective circles
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Stain with Coomassie for 30 seconds

Destain until protein dots are clear and darker than the background.

Save 20 μl gel samples of each fraction.

Desalt using PD-10 column or similar into PEM-100.
Remove top and bottom cap of column.

Allow buffer to completely drain by gravity flow.

Add 10 ml PEM-100+ATP and allow to completely enter gel bed.
Add 500

l of elution with protein (determ ined by dot b

Put new 1.5 ml tube under column.

Add 1 ml PEM-100+ATP and collect eluate. Save 20 μl gel sample.
Aliquot into 20 μl aliquots.

Drop freeze in liquid nitrogen and store in -80°C.

Pre-Bundled Gliding Assay with MAP65

For the gliding assays using pre-bundled microtubules, the following Motility Mix was
required:
Pre-bundled MT, ATP Regenerating, Motility Mix: 35 μM Taxol, 35 mM DTT, desired amount
of MAP65 and microtubules (see below for the pre-bundled microtubules), 1 mM ATP, 1.9
μM Phosphocreatine, 68 μg/ml Creatine Phosphokinase, 4.3 mg/mL glucose, and 0.4 μl
deoxy for every 10 μl, volume with PEM-100. Add the ATP, Phosphocreatine, Creatine
Phosphokinase, glucose, and deoxy just before insertion into the chamber.
Deoxy: 10 mg/mL glucose oxidase, 4.7 mg/mL catalase, in double distilled water. Spin down
solids and remove the saturated solution at the top. Store in 4°C for up to a week.
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BSA Wash Buffer: 5mg/mL BSA, 60 μM Taxol, 20 mM DTT, volume with PEM-100. Make the
day of the assay and do not store for reuse.

Experiment:
In order to obtain dynamic organizations of microtubules that continue to be motile in the
chamber, we need to pre-bundle microtubules by mixing microtubules with MAP65.
Make Pre-bundled MT, ATP Regenerating, Motility Mix and incubate for at least 30 minutes
to bundle microtubules. Do not include the ATP, ATP regenerating system, or deoxy.
Make Chamber Wash and standard flow chamber (13.1.1).

About 10 minutes before make Pre-bundled MT, ATP Regenerating, Motility Mix incubation
is done take out kinesin to thaw in hand.

About 5 minutes before incubation is complete, flow in 10 μl of kinesin. Incubate for at least
5 minutes. Another aliquot may be needed depending on number of active kinesin in the
preparation, and should be assessed with the standard gliding assay.
When incubation is complete add ATP, glucose, deoxy, and regenerating system.
Flow in 10 μl of chamber wash to the flow chamber.

Flow in 10 μl of the Pre-bundled MT, ATP Regenerating, Motility Mix and image
microtubules using epi-fluorescence with shuttering between frames. If bundles are
particularly three-dimensional, time series imaging can include z-stacks using a motorized
stage with a z-stepper.

Flow-in Dynamic Bundling
Reagents:

PEM-100: 100mM Na-PIPES, 1mM MgSO4, 1mM EGTA, pH 6.8, volume with double distilled
water

Microtubule Dilution: 1μL 2mM Taxol, 1μL stock microtubules, volume to needed
concentration with PEM-100

31

MAP solution: 1μL 2mM Taxol, amount of MAP needed, volume with PEM-100 to needed
concentration
Make a standard cross-flow chamber

Flow in 10μL of microtubule dilution and image using epi-fluorescence with no delay
towards one end of the chamber.
On the other end of the chamber flow in 10μL of MAP solution and observe bundling.
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